Skip to main content
. 2023 Jan 10;24(2):1383. doi: 10.3390/ijms24021383

Table 1.

NOTCH1 pathway targeting strategies.

Inhibitor Target Mechanism References
P2207, P217564 USP7 Small molecule inhibiting USP7-dependent NOTCH1
deubiquitination
[6,7]
PF-0308414 γ-secretase complex Small molecule inhibiting γ-secretase dependent
NOTCH1 cleavage
[64,68,70]
RO4929097 γ-secretase complex Small molecule inhibiting γ-secretase dependent
NOTCH1 cleavage
[64,68]
AL101/AL102 γ-secretase complex Small molecule inhibiting γ-secretase dependent
NOTCH1 cleavage
[64,68,69]
OMP-52M51
(Brontictuzumab)
NOTCH1 Antibody interfering with NOTCH1-ligand
interaction
[71]
Mab604.107 NOTCH1 Antibody interfering with NOTCH1-ligand
interaction
[72]
Demcizumab DLL4 Antibody interfering with NOTCH-DLL4 ligand
interaction
[73]
Enoticumab DLL4 Antibody interfering with NOTCH-DLL4 ligand
interaction
[74]
ZLDI-8 ADAM17 Small molecule inhibiting ADAM17-dependent
NOTCH1 cleavage
[79]
NOTCH decoys NOTCH1 Soluble inhibitors interfering with NOTCH1-ligand interaction [80]
SAHM MAML1 Stapled α-helical peptides interfering with MAML1
binding to NOTCH transcriptional complex
[81]
NADI-351 NOTCH Ternary complex (NTC) Small molecule disrupting NTC [82]
Thapsigargin SERCA Small molecule inhibiting SERCA activity [83]
CAD204520 SERCA Small molecule inhibiting SERCA activity [84]
6-alkynyl and
6-alkenyl fucose
POFUT1 L-fucose analogs disrupting NOTCH1-DELTA-ligand
interactions
[85]